Champions Oncology, Inc. (CSBR)
4.97
+0.01
(+0.20%)
USD |
NASDAQ |
Aug 24, 16:00
4.99
+0.02
(+0.40%)
After-Hours: 20:00
Champions Oncology Revenue (Quarterly) : 13.84M for April 30, 2026
Revenue (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 13.84M |
| January 31, 2026 | 16.56M |
| October 31, 2025 | 15.04M |
| July 31, 2025 | 14.00M |
| April 30, 2025 | 12.36M |
| January 31, 2025 | 17.04M |
| October 31, 2024 | 13.49M |
| July 31, 2024 | 14.06M |
| April 30, 2024 | 14.00M |
| January 31, 2024 | 12.02M |
| October 31, 2023 | 11.57M |
| July 31, 2023 | 12.56M |
| April 30, 2023 | 13.07M |
| January 31, 2023 | 12.77M |
| October 31, 2022 | 14.28M |
| July 31, 2022 | 13.74M |
| April 30, 2022 | 12.88M |
| January 31, 2022 | 13.19M |
| October 31, 2021 | 11.79M |
| July 31, 2021 | 11.25M |
| April 30, 2021 | 10.56M |
| January 31, 2021 | 10.81M |
| October 31, 2020 | 10.12M |
| July 31, 2020 | 9.547M |
| April 30, 2020 | 8.75M |
| Date | Value |
|---|---|
| January 31, 2020 | 9.012M |
| October 31, 2019 | 7.625M |
| July 31, 2019 | 6.737M |
| April 30, 2019 | 7.718M |
| January 31, 2019 | 6.43M |
| October 31, 2018 | 6.693M |
| July 31, 2018 | 6.225M |
| April 30, 2018 | 4.922M |
| January 31, 2018 | 5.082M |
| October 31, 2017 | 5.203M |
| July 31, 2017 | 5.033M |
| April 30, 2017 | 3.72M |
| January 31, 2017 | 3.565M |
| October 31, 2016 | 4.457M |
| July 31, 2016 | 3.67M |
| April 30, 2016 | 2.837M |
| January 31, 2016 | 2.552M |
| October 31, 2015 | 2.971M |
| July 31, 2015 | 2.822M |
| April 30, 2015 | 3.241M |
| January 31, 2015 | 1.829M |
| October 31, 2014 | 1.882M |
| July 31, 2014 | 1.912M |
| April 30, 2014 | 2.458M |
| January 31, 2014 | 3.69M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 707.33M |
| Avantor, Inc. | 1.692B |
| Personalis, Inc. | 22.36M |
| Adaptive Biotechnologies Corp. | 71.55M |
| 10X Genomics, Inc. | 151.04M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.667M |
| Total Expenses (Quarterly) | 14.50M |
| EPS Diluted (Quarterly) | -0.048 |
| Enterprise Value | 68.87M |
| Gross Profit Margin (Quarterly) | 48.77% |
| Profit Margin (Quarterly) | -4.82% |
| Earnings Yield | -1.63% |
| Normalized Earnings Yield | -1.634 |